Skip to content

Alzheimer’s Disease: Merry Life Launches Global Phase II Trial of TML-6

Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer’s disease (AD). TML-6 combines multiple mechanisms, including anti-oxidative effects (Nrf2 activation), melioration of autophagy function (autolysosomal activation), anti-amyloid accumulation (?-amyloid clearance), and anti-inflammatory effects (through NF-?B inhibition) through autolysosome pathway in neurons and microglia to remove intraneuronal and extracellular amyloid accumulation, representing the first in human multi-target strategy for AD treatment. The Phase I trial showed excellent safety, tolerability, and pharmacokinetics at 100–200 mg in both healthy and elderly adults. TML-6 will now advance to a Phase II 19 site trial across the United States, Sweden, and Taiwan after FDA approval. This 12-month study will enroll 210 patients with mild cognitive impairment (MCI) or mild dementia. Primary endpoints will include neuropsychological assessments (CDR-SB, iADRS) and… 

BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second dose cohorts will now be initiated. The EXIST study evaluates exidavnemab, a drug candidate being developed as a treatment for Parkinson’s disease and Multiple System Atrophy (MSA). The first cohort in the ongoing clinical Phase 2a study EXIST evaluated a lower dose of exidavnemab compared to placebo in patients with Parkinson’s disease. An interim safety review showed that exidavnemab was safe and well tolerated. The positive outcome will result in the initiation of two further cohorts, to evaluate a higher dose of exidavnemab in comparison with placebo in patients with Parkinson’s disease as well as MSA.

Deutsche Telekom builds European AI infrastructure with NVIDIA for industry

NVIDIA and Deutsche Telekom are building the world's first industrial AI cloud for European manufacturers on German soil. On the one hand, this paves the way for AI gigafactories, and on the other, it offers the opportunity to advance Germany as an industrial location with rapid AI implementation and build a competitive advantage. The industrial AI cloud is expected to be implemented by 2026 at the latest. Cutting-edge technology from Nvidia, secure infrastructure from Telekom The AI factory in Germany will support industrial AI workloads for European manufacturers. It will feature over 10,000 GPUs. This will be ensured by NVIDIA DGX B200 systems and RTX Pro Server GPUs, running NVIDIA CUDA-X, RTX, and Omniverse accelerated workloads from leading software providers. Deutsche Telekom is providing its secure, sovereign, and fast infrastructure and is responsible for data centers, operations, sales, as well as security and AI solutions. It also guarantees that European values such as data protection and data security are adhered to and that data will only be… 

Pregnancy: Wild sex does no harm

Sex during pregnancy: Debunking myths, enjoying pleasure Berlin, June 13, 2025 – Sex during pregnancy is a topic passionately discussed in online forums. However, along with the anticipation of a baby come many questions: How does our love life change? What is safe, and what is not? While helpful tips circulate on the internet, old wives' tales often cause uncertainty and unnecessary stress. The editorial team at Apotheken Umschau ELTERN magazine dispels misconceptions and shows how couples can enjoy this special time. Desire and intimacy during pregnancy Many expectant mothers experience increased desire and more intense orgasms, especially in the middle of their pregnancy. The reason lies in hormonal changes: elevated estrogen and progesterone levels promote blood flow to the vagina and clitoris, and the vaginal lining is moister. Additionally, many pregnant women are more aware of their bodies, which can increase arousal… 

RPTU students revolutionize cancer treatment: Focus on sustainable antibody production

Kaiserslautern, June 13, 2025 – How can a promising antibody against cancer be produced more efficiently, cost-effectively, and sustainably? This question is driving bachelor students of Molecular Biology at the Rhineland-Palatinate Technical University Kaiserslautern-Landau (RPTU). With their innovative project "SUSPACT," they are participating in the world's largest synthetic biology competition, the "International Genetically Engineered Machine" (iGEM). Supported by in-depth knowledge, practical experience, and excellent supervision, they are developing solutions that could revolutionize cancer treatment. SUSPACT: Sustainable Antibodies for Cancer Treatment In the project "Sustainable Use of Synthetically Produced Antibodies for Cancer Treatment" (SUSPACT), a 13-member team has been dedicated since September 2024 to optimizing the production of the antibody Cetuximab. This antibody is successfully used in colon and head and neck cancer but is complex and expensive to produce. The students' goal is to make this process simpler, more resource-efficient, and more cost-effective. Cetuximab targets the Epidermal Growth Factor Receptor (EGFR),...

OFET: Surface defects hinder current transport in organic electronics more than expected

  • News

A research team from Philipps University Marburg and the Max Planck Institute for Solid State Research in Stuttgart has demonstrated that surface defects at the interfaces of organic transistors influence current transport significantly more than previously assumed. The study, published in the journal "Advanced Materials," focuses on the targeted treatment of the interface between the insulator and the organic semiconductor. Transistors where the usual hydroxyl groups on the insulator surface were removed showed better transport properties for both electrons and holes. Previously, it was assumed that electron transport, in particular, is impaired by such surface defects, known as trap states. However, current results show that hole transport also suffers considerably. The researchers investigated the organic components under high vacuum and at different temperatures to rule out disruptive influences from air humidity or oxygen. This allowed them to precisely show for the first time how trap states affect the performance of organic transistors. The study suggests that not only the...

Iran's Asymmetric Retaliation: Bioterrorism and Dirty Bombs as Threats After Israel's Attack – Paths to De-escalation

On June 13, 2025, Israel launched a "preemptive strike" against Iranian nuclear facilities, as reported by Israeli and international media. This attack, which according to reports also killed the head of Iran's Revolutionary Guard, Hossein Salami, has significantly escalated tensions in the Middle East. Iran is threatening retaliation, and asymmetric attacks, including bioterrorism and so-called "dirty bombs," are the focus of security analyses. This analysis examines Iran's potential asymmetric retaliatory measures against the USA, with a particular focus on bioterrorism and radiological weapons, based on peer-reviewed studies and official data. Finally, paths to de-escalation are outlined to prevent a regional conflagration. 1. Background: Israel's Attack and Iran's Strategic Position The Israeli attack targeted strategic sites in Iran, including nuclear facilities perceived as a threat to Israel's security. According to official statements, the USA, Israel's closest ally, was not directly involved, but it did recall its embassy staff… 

Merz's Silence on the Mask Affair: An Ethical and Moral Misstep

  • News

Introduction The mask affair surrounding former Federal Minister of Health Jens Spahn continues to cast a long shadow over German politics, particularly the Christian Democratic Union (CDU) and its Chancellor Friedrich Merz. During the Corona pandemic, masks worth billions were procured under Spahn's leadership, a significant portion of which was destroyed unused, causing a financial loss of approximately 2.3 billion euros for taxpayers. A report by special investigator Margaretha Sudhof also reveals that Spahn favored a logistics company from his home region without a tender, raising questions of cronyism and mismanagement. Friedrich Merz, who has served as Chancellor since May 2025, is under criticism for continuing to politically shield Spahn despite these allegations by appointing him chairman of the CDU/CSU parliamentary group. This decision is considered by many to be a violation of ethical and moral standards, as it undermines the principles of transparency, responsibility, and integrity… 

Gut Microbes Defeat Pancreatic Cancer

A new international cooperation study suggests that pancreatic cancer could be detected early in the future through gut microbes. Gut microbes could also offer solutions for therapy development. Researchers from HUS, the University of Helsinki, the University of Jyväskylä (Finland), and Iran have jointly gained new insights into gut microbes in connection with pancreatic cancer. The researchers analyzed gut microbes from Finnish and Iranian pancreatic cancer patients and their healthy peers. A total of over 180 people participated in the study. The study is part of the doctoral dissertation of doctoral student Heidelinde Sammallahti at the University of Helsinki. The same gut microbes associated with pancreatic cancer were found in patients regardless of their geographical location and ethnic origin. The gut flora of patients with pancreatic cancer contained significantly more facultative pathogens and significantly fewer beneficial bacteria than in the healthy comparison group. In particular, beneficial bacteria from the class of Clostridia, such as the butyric acid-producing Lachnospiraceae, Butyricicoccaceae... 

New test promises more efficient screening for carriers of Fragile X syndrome

  • News

Researchers have developed an innovative new nanopore sequencing test to identify carriers of Fragile X syndrome (FXS), the most common cause of monogenic autism spectrum disorders and inherited intellectual disabilities. The study, published in the Journal of Molecular Diagnostics, published by Elsevier, addresses the urgent need for a screening tool to identify carriers of FXS more comprehensively, faster, more efficiently, and more cost-effectively compared to current methods, thereby enabling better-informed genetic counseling. FXS affects approximately 1 in 7,000 women and 1 in 4,000 men worldwide. Common features include mild to severe intellectual disability, developmental delays in speech and motor skills, behavioral and social problems such as ADHD-like symptoms and autism spectrum disorder symptoms, sensory sensitivities, and sometimes characteristic physical features. Lead researcher Qiwei Guo, PhD, Department of Central Laboratory, Department of Obstetrics and Gynecology, Fujian Key Clinical Specialty of Laboratory Medicine, Women and Children's Hospital, Medical College, Xiamen University, Xiamen, China, says: "Also...